Application of different concentrations of ropivacaine in ultrasound-guided saphenous nerve combined with sciatic nerve block in prehospital analgesia for patients with emergency lower limbs trauma

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2200058662

Enrollment

Unknown

Registered

2022-04-13

Start date

2022-05-01

Completion date

Unknown

Last updated

2024-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain management in emergency lower limbs trauma

Interventions

Group1:Ultrasound-guided saphenous nerve block combined with sciatic nerve block (0.25% ropivacaine 20ml each)

Group 2:Ultrasound-guided saphenous nerve block combined with sciatic nerve block (0.375% ropivacaine 20ml each)

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. ASA grade I or II patients; 2. Age ranged from 18 to 65 years.

Exclusion criteria

Exclusion criteria: 1. Coagulation dysfunction; 2. Infection at puncture site; 3. Acute and chronic pain before operation; 4. Neuromuscular junction disease patients; 5. Diabetes mellitus; 6. Cognitive dysfunction, drug addiction history; 7. Moderate to severe liver and kidney dysfunction; 8. BMI > 32.

Design outcomes

Primary

Measure	Time frame
VAS Score in Perioperative Period;	—

Secondary

Measure	Time frame
Length of hospitalization stay;Anesthesia-related complications;Time from admission to surgery;Patient's Satisfaction;	—

Countries

China

Contacts

Public ContactLi Hu

The Second Hospital of Jiaxing

517739395@qq.com+86 18257333506

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026